ARCHIVES

Rescission Cuts $5-6 Mil. From NCI FY94 Appropriations , Affects Intramural Program

This article is from The Cancer Letter archive.

Vol. 20 No. 10 | March 11, 1994

Download PDF Visit The Full Archive

Related Articles

Pennsylvania House Approves Bills Establishing Control, Research Funds With Cigarette Tax

August 11, 1978

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990

NCI Boosts Funding For Cooperative Groups by $25 Million, Cuts Overall Accrual by 20 Percent, to 20,000 Patients

November 11, 2011

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

April 28, 1995

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

April 15, 1994